Location History:
- Durham, NC (US) (2016)
- Raleigh, NC (US) (2017)
- Cary, NC (US) (2019 - 2023)
Company Filing History:
Years Active: 2016-2023
Title: The Innovative Contributions of Kelly Mercier
Introduction
Kelly Mercier is a notable inventor based in Cary, NC (US), recognized for his significant contributions to the field of diabetes risk evaluation. With a total of four patents to his name, Mercier has made strides in developing methods and systems that enhance the understanding of diabetes progression.
Latest Patents
Among his latest patents, Mercier has developed multi-parameter diabetes risk evaluations. These methods, systems, and circuits are designed to assess a subject's risk of developing type 2 diabetes or prediabetes. The innovative approach utilizes at least one defined mathematical model of risk progression, which can stratify risk for patients who have the same glucose measurement. Notably, the model incorporates NMR-derived measurements of GlycA and various selected lipoprotein components from at least one biosample of the subject.
Career Highlights
Mercier's career is marked by his work at Liposcience, Inc., where he has been instrumental in advancing research related to diabetes risk assessment. His expertise in this area has led to the development of groundbreaking technologies that aim to improve patient outcomes.
Collaborations
Throughout his career, Mercier has collaborated with esteemed colleagues, including James D. Otvos and Irina Y. Shalaurova. These partnerships have fostered an environment of innovation and have contributed to the success of his projects.
Conclusion
In summary, Kelly Mercier's work in diabetes risk evaluation showcases his commitment to innovation and improving healthcare solutions. His patents reflect a deep understanding of the complexities of diabetes and a dedication to advancing medical technology.